SlideShare a Scribd company logo
1 of 28
– J . K . R O W L I N G
“Depression isn't just being a bit sad. It's feeling nothing.
It's not wanting to be alive anymore”
I N T R O D U C T I O N
Depression:
Not a single neurotransmitter disorder,
but represents a continuum of
environmental, genetic and
neurochemical determinants that
occupy a distinct role.
Many overlapping symptoms as well as
biological mechanisms characterize
mood disorders
Harvey et al., 2008; Fone & Porkess, 2008; Anderson et al., 2013; Cotton et al., 2012
5HTDA
NA
G E N E T I C S
E N V I R O N M E N T
N E U R O -
C H E M I S T R Y
I N T R O D U C T I O N
M O N O A M I N E S
C I R C A D I A N R H Y T H M S
O X I D A T I V E S T R E S S &
I M M U U N E -
I N F L A M M A T O R Y
D Y S F U N C T I O N
N E U R O T R O P H I C
F A C T O R S
H P A - A X I S &
C O R T I C O S T E R O N E
G A B A - G L U T A M A T E
S I G N A L I N G
H
Y
P
O
T
H
E
S
E
S
BDNF
Neurogenesis
Increased activity of
the HPA-axis
Production of
inflammatory
cytokines (TNF-α)
Increased
secretion of
glucocorticoids
Atrophy & death of
neurons
Circadian Rhythms
Monoamines
(5HT;NA;DA)
TNF-α; INF-γ; IL-6
Hippocampal
neurogenesis
Major
Depression
Nestler et al., 2002; Harvey et al., 2003; Savitz & Drevents, 2009; McClung, 2013
S O C I A L I S O L A T I O N
R E A R I N G
Early-life SIR is known to produce changes
consistent with the neurodevelopmental hypothesis
of depression.
In our hands this model demonstrated excellent
validity for modeling the neurobiology and
behavioral profile for schizophrenia.
To the best of our knowledge, the ability of
agomelatine to reverse SIR-induced bio-
behavioral changes has not been undertaken.
SIRB E H A V I O R A L L E V E L :
 N e o p h o b i a
 A g g r e s s i o n
 C o g n i t i v e r i g i d i t y
 I m p a i r e d s e n s o r i m o t o r
& s o c i a l i n t e r a c t i o n
M o n o a m i n e r g i c
D e f i c i t s
N E U R O - B I O L O G I C A L
L E V E L :
 R e d u c e d P F C v o l u m e
 D e c r e a s e d c o r t i c a l &
h i p p o c a m p a l s y n a p t i c
p l a s t i c i t y
A G O M E L A T I N E
MT1 MT2
5-HT2C
The Biological Clock
Mignot E. et al. Nat Neurosci. 2002; 5:1071-5
Turek FE, et al. Arch Neurol. 2001.
Biological, physiological, and behavioral parameters
Suprachiasmatic nuclei
(SCN)
(Anterior hypothalamus)
SCN
 5HT
PVN Pineal
Retina
Internal Biological Clock
Melatonin
Raphe Nuclues
Primary node of action
Mechanism
Anxiolytic
Devoid of 5-HT side
effects
C Munoz, Servier; Banasr et al., 2006; Racagni et al., 2011
R E S E A C H P R O B L E M
Antidepressant efficacy is disappointing – 55-60% effective
with treatments restricted to the monoaminergic system
Circadian rhythm plays a major role to ensure optimal
functioning making it a therapeutic target in mood disorders
Agomelatine's action involves:
• resynchronizing of circadian rhythms
(via regulation of 5HT vs. melatonergic activity in SCN)
• direct effect on frontal NA/DA release (via 5HT2c antag)
• indirect action by modifying monoamine release
in brain stem (via re-entrainment of biological rhythms).
METHODS
Male Sprague-Dawley rats (300-350g;
Vivarium, North West University)
randomly allocated to groups – 12
rats/group
PND 21 the animals was randomized
to SIR (1 animal/cage) or social
rearing (3-4 animals/cage) for 8 weeks
Animals were handled according to the
code of ethics in research (Ethics
number NWU-00154-14-S5).
A N I M A L S
We are all mice in a
giant experimental
maze, scurrying around
frantically, trying to
find our way
through…
G E N E R A L I N F O R M A T I O N :
1 . 1 % H E C
2 . A g o m e l a t i n e ( 4 0 m g / k g ) 0 8 H 0 0
3 . A g o m e l a t i n e ( 4 0 m g / k g ) 1 6 H 0 0
PND 21 8 Weeks Isolation Period 14 Days Treatment
Behavioral Testing
(13+14)
1 R a t / c a g e
3 - 4 R a t s / c a g e
Locomotor activity
Forced Swim Test (FST)
S T U D Y D E S I G N
O p e n F i e l d T e s t
( O F T )
OFT was to measure locomotor activity
which is a parameter used to test the general
ability of the animal to move and negotiate its
surrounding.
On the day of testing (Day 14), rats were
placed in the OFT arena and allowed to
explore the arena for 10min under low light.
During this time the rat was video-taped.
1 hour after locomotor activity was assessed,
a final forced swim test was done.
F o r c e d S w i m T e s t
( F S T )
Assessment of depressive-like symptoms:
Assessed using the forced swim test (FST) on
day 14.
24h prior to the final swim test, rats were
subjected to 15min of pre-swimming in
transparent perspex cylinders containing
30cm of clean water (25 ˚± 2C).
Immobility, climbing (NA-behaviors), diving
and swimming (5HT-behaviors),
Were recorded.
Results
R E S U L T S
Locomotor
Two-way ANOVA, Tukey Post-Hoc Test
Immobility
Two-way ANOVA, Tukey Post-Hoc Test
Struggle
Two-way ANOVA, Tukey Post-Hoc Test
Swimming
Two-way ANOVA, Tukey Post-Hoc Test
Conclusion
Agomelatine has antidepressant
effects in SIR.
Time of dosing independence.
Late afternoon dosing
evokes NA-related (struggling)
behaviors
without affecting 5HT
Morning dosing may involve
monoamine-independent actions
– neurochemical data in progress
People who die by suicide don’t want to end their lives,
they want to end their pain…
S T U D Y L E A D E R : P R O F B . H . H A R V E Y
C O - S T U D Y L E A D E R : D R . M . M Ö L L E R - W O L M A R A N S
S E R V I E R : F R É D É R I Q U E L A M O U R
C E C I L I A G A B R I E L - G A R C I A
C A R M E N M U N O Z
F U N D I N G : M R C
S E R V I E R ( D R U G S )
N R F
Acknowledgements
T H A N K Y O U

More Related Content

Similar to D. Coutts

Hernandez IL-6
Hernandez IL-6Hernandez IL-6
Hernandez IL-6
Kevin Liu
 
ICC Keynote Presentation 2013 N Ryan
ICC Keynote Presentation 2013 N RyanICC Keynote Presentation 2013 N Ryan
ICC Keynote Presentation 2013 N Ryan
Nicole Ryan
 
Article 4 biofeedback mag-04-sad
Article 4  biofeedback mag-04-sadArticle 4  biofeedback mag-04-sad
Article 4 biofeedback mag-04-sad
Mind Alive
 
UCSB Research Paper
UCSB Research PaperUCSB Research Paper
UCSB Research Paper
Megan Burrey
 
Joshua_Davila_PosterDraftSANSconference
Joshua_Davila_PosterDraftSANSconferenceJoshua_Davila_PosterDraftSANSconference
Joshua_Davila_PosterDraftSANSconference
Joshua Davila
 
Hanipsych, updates on neurobiology and neurotoxicity of depression
Hanipsych, updates on neurobiology and neurotoxicity of depressionHanipsych, updates on neurobiology and neurotoxicity of depression
Hanipsych, updates on neurobiology and neurotoxicity of depression
Hani Hamed
 
Science Presentation
Science PresentationScience Presentation
Science Presentation
cmc388
 

Similar to D. Coutts (20)

Van stegeren(2007) prog brain res
Van stegeren(2007) prog brain resVan stegeren(2007) prog brain res
Van stegeren(2007) prog brain res
 
TheNextWeb: Biohacking for the 21st Century
TheNextWeb: Biohacking for the 21st CenturyTheNextWeb: Biohacking for the 21st Century
TheNextWeb: Biohacking for the 21st Century
 
Journal presentation on essential tremor
Journal presentation on essential tremorJournal presentation on essential tremor
Journal presentation on essential tremor
 
Hernandez IL-6
Hernandez IL-6Hernandez IL-6
Hernandez IL-6
 
Paper
PaperPaper
Paper
 
ICC Keynote Presentation 2013 N Ryan
ICC Keynote Presentation 2013 N RyanICC Keynote Presentation 2013 N Ryan
ICC Keynote Presentation 2013 N Ryan
 
Article 4 biofeedback mag-04-sad
Article 4  biofeedback mag-04-sadArticle 4  biofeedback mag-04-sad
Article 4 biofeedback mag-04-sad
 
UCSB Research Paper
UCSB Research PaperUCSB Research Paper
UCSB Research Paper
 
Neuroactive steroids
Neuroactive steroidsNeuroactive steroids
Neuroactive steroids
 
Neuro-endocrine basis of Behavioural Disorders in Farm Animals
Neuro-endocrine basis of Behavioural Disorders in Farm AnimalsNeuro-endocrine basis of Behavioural Disorders in Farm Animals
Neuro-endocrine basis of Behavioural Disorders in Farm Animals
 
Premature ejaculation
Premature ejaculation Premature ejaculation
Premature ejaculation
 
Senior thesis(2015)_Ganesh
Senior thesis(2015)_GaneshSenior thesis(2015)_Ganesh
Senior thesis(2015)_Ganesh
 
Schizophrenia~Ketamine~Pterostilbene
Schizophrenia~Ketamine~PterostilbeneSchizophrenia~Ketamine~Pterostilbene
Schizophrenia~Ketamine~Pterostilbene
 
Joshua_Davila_PosterDraftSANSconference
Joshua_Davila_PosterDraftSANSconferenceJoshua_Davila_PosterDraftSANSconference
Joshua_Davila_PosterDraftSANSconference
 
BRAINY. Stress and the Brain
BRAINY. Stress and the BrainBRAINY. Stress and the Brain
BRAINY. Stress and the Brain
 
Hanipsych, updates on neurobiology and neurotoxicity of depression
Hanipsych, updates on neurobiology and neurotoxicity of depressionHanipsych, updates on neurobiology and neurotoxicity of depression
Hanipsych, updates on neurobiology and neurotoxicity of depression
 
Week 3 the neural basis of consciousness overview of important clinical cas...
Week 3  the neural basis of consciousness  overview of important clinical cas...Week 3  the neural basis of consciousness  overview of important clinical cas...
Week 3 the neural basis of consciousness overview of important clinical cas...
 
Melatonin Agonists
Melatonin AgonistsMelatonin Agonists
Melatonin Agonists
 
Science Presentation
Science PresentationScience Presentation
Science Presentation
 
FUNÇÃO COGNITIVA NA PERI E NA PÓS MENOPAUSA: O QUE JÁ SABEMOS?
FUNÇÃO COGNITIVA NA PERI E NA PÓS MENOPAUSA: O QUE JÁ SABEMOS?FUNÇÃO COGNITIVA NA PERI E NA PÓS MENOPAUSA: O QUE JÁ SABEMOS?
FUNÇÃO COGNITIVA NA PERI E NA PÓS MENOPAUSA: O QUE JÁ SABEMOS?
 

D. Coutts

  • 1.
  • 2. – J . K . R O W L I N G “Depression isn't just being a bit sad. It's feeling nothing. It's not wanting to be alive anymore”
  • 3. I N T R O D U C T I O N
  • 4. Depression: Not a single neurotransmitter disorder, but represents a continuum of environmental, genetic and neurochemical determinants that occupy a distinct role. Many overlapping symptoms as well as biological mechanisms characterize mood disorders Harvey et al., 2008; Fone & Porkess, 2008; Anderson et al., 2013; Cotton et al., 2012 5HTDA NA G E N E T I C S E N V I R O N M E N T N E U R O - C H E M I S T R Y I N T R O D U C T I O N
  • 5. M O N O A M I N E S C I R C A D I A N R H Y T H M S O X I D A T I V E S T R E S S & I M M U U N E - I N F L A M M A T O R Y D Y S F U N C T I O N N E U R O T R O P H I C F A C T O R S H P A - A X I S & C O R T I C O S T E R O N E G A B A - G L U T A M A T E S I G N A L I N G H Y P O T H E S E S
  • 6. BDNF Neurogenesis Increased activity of the HPA-axis Production of inflammatory cytokines (TNF-α) Increased secretion of glucocorticoids Atrophy & death of neurons Circadian Rhythms Monoamines (5HT;NA;DA) TNF-α; INF-γ; IL-6 Hippocampal neurogenesis Major Depression Nestler et al., 2002; Harvey et al., 2003; Savitz & Drevents, 2009; McClung, 2013
  • 7. S O C I A L I S O L A T I O N R E A R I N G
  • 8. Early-life SIR is known to produce changes consistent with the neurodevelopmental hypothesis of depression. In our hands this model demonstrated excellent validity for modeling the neurobiology and behavioral profile for schizophrenia. To the best of our knowledge, the ability of agomelatine to reverse SIR-induced bio- behavioral changes has not been undertaken. SIRB E H A V I O R A L L E V E L :  N e o p h o b i a  A g g r e s s i o n  C o g n i t i v e r i g i d i t y  I m p a i r e d s e n s o r i m o t o r & s o c i a l i n t e r a c t i o n M o n o a m i n e r g i c D e f i c i t s N E U R O - B I O L O G I C A L L E V E L :  R e d u c e d P F C v o l u m e  D e c r e a s e d c o r t i c a l & h i p p o c a m p a l s y n a p t i c p l a s t i c i t y
  • 9. A G O M E L A T I N E
  • 10. MT1 MT2 5-HT2C The Biological Clock Mignot E. et al. Nat Neurosci. 2002; 5:1071-5 Turek FE, et al. Arch Neurol. 2001. Biological, physiological, and behavioral parameters Suprachiasmatic nuclei (SCN) (Anterior hypothalamus) SCN  5HT PVN Pineal Retina Internal Biological Clock Melatonin Raphe Nuclues
  • 11. Primary node of action Mechanism Anxiolytic Devoid of 5-HT side effects C Munoz, Servier; Banasr et al., 2006; Racagni et al., 2011
  • 12. R E S E A C H P R O B L E M
  • 13. Antidepressant efficacy is disappointing – 55-60% effective with treatments restricted to the monoaminergic system Circadian rhythm plays a major role to ensure optimal functioning making it a therapeutic target in mood disorders Agomelatine's action involves: • resynchronizing of circadian rhythms (via regulation of 5HT vs. melatonergic activity in SCN) • direct effect on frontal NA/DA release (via 5HT2c antag) • indirect action by modifying monoamine release in brain stem (via re-entrainment of biological rhythms).
  • 15. Male Sprague-Dawley rats (300-350g; Vivarium, North West University) randomly allocated to groups – 12 rats/group PND 21 the animals was randomized to SIR (1 animal/cage) or social rearing (3-4 animals/cage) for 8 weeks Animals were handled according to the code of ethics in research (Ethics number NWU-00154-14-S5). A N I M A L S We are all mice in a giant experimental maze, scurrying around frantically, trying to find our way through…
  • 16. G E N E R A L I N F O R M A T I O N : 1 . 1 % H E C 2 . A g o m e l a t i n e ( 4 0 m g / k g ) 0 8 H 0 0 3 . A g o m e l a t i n e ( 4 0 m g / k g ) 1 6 H 0 0 PND 21 8 Weeks Isolation Period 14 Days Treatment Behavioral Testing (13+14) 1 R a t / c a g e 3 - 4 R a t s / c a g e Locomotor activity Forced Swim Test (FST) S T U D Y D E S I G N
  • 17. O p e n F i e l d T e s t ( O F T ) OFT was to measure locomotor activity which is a parameter used to test the general ability of the animal to move and negotiate its surrounding. On the day of testing (Day 14), rats were placed in the OFT arena and allowed to explore the arena for 10min under low light. During this time the rat was video-taped. 1 hour after locomotor activity was assessed, a final forced swim test was done.
  • 18. F o r c e d S w i m T e s t ( F S T ) Assessment of depressive-like symptoms: Assessed using the forced swim test (FST) on day 14. 24h prior to the final swim test, rats were subjected to 15min of pre-swimming in transparent perspex cylinders containing 30cm of clean water (25 ˚± 2C). Immobility, climbing (NA-behaviors), diving and swimming (5HT-behaviors), Were recorded.
  • 19. Results R E S U L T S
  • 25. Agomelatine has antidepressant effects in SIR. Time of dosing independence. Late afternoon dosing evokes NA-related (struggling) behaviors without affecting 5HT Morning dosing may involve monoamine-independent actions – neurochemical data in progress
  • 26. People who die by suicide don’t want to end their lives, they want to end their pain…
  • 27. S T U D Y L E A D E R : P R O F B . H . H A R V E Y C O - S T U D Y L E A D E R : D R . M . M Ö L L E R - W O L M A R A N S S E R V I E R : F R É D É R I Q U E L A M O U R C E C I L I A G A B R I E L - G A R C I A C A R M E N M U N O Z F U N D I N G : M R C S E R V I E R ( D R U G S ) N R F Acknowledgements
  • 28. T H A N K Y O U